Two companies have joined forces to improve the reliability and credibility of data gained from commercial poultry trials.
Agri-tech company Poultry Sense and microbial specialists Lallemand Animal Nutrition say their partnership demonstrates their commitment to the industry at a time when accurate data is becoming increasingly important to improve farm business performance.
Poultry Sense veterinary adviser Barry Thorp said: “We are really excited to be working with an innovative company like Lallemand that has similar objectives to us – improving the health, welfare and efficiency of commercial livestock.”
This trial will see Poultry Sense install new real-time data monitoring solution on two poultry farms that work with Lallemand to see what impact introducing new feed products has on bird health, welfare and productivity.
Mr Thorp said the technology would demonstrate whether introducing or changing products had an impact on daily liveweight gain. Any changes in bird health or performance would be identified and analysed by researchers.
“This data will also provide Lallemand with the ammunition required to stand out in a competitive market when, providing their customers with accurate data that will help increase their confidence in these new options.”
Hannah Elliott, monogastric sales and technical support at Lallemand Animal Nutrition, said positive changes in behaviour and increased stress resistance were often observed when using the company’s feed products and the firm wanted to capture this.
“We’re eager to embrace this new, innovative technology, which will enable us to look at poultry houses on a zone-by-zone basis as opposed to a whole house basis. This will give us much more accurate insight on how birds are performing and behaving when our products are used.
“With the Poultry Sense team’s expertise, we’re hoping to interpret and analyse this extensive real-time farm data and use it to support the existing European and technical data we have, as well as the good feedback we get from customers.”
Ms Elliott said the research would help maximise the efficiency and reliability of commercial trials. “We value the importance of data in continuous progression and working with our customers to enhance welfare and take production forward to the next level.”